2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Altro …
booklooker.de buecher.de GmbH & Co. KG Costi di spedizione:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - copertina rigida, flessible
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
booklooker.de |
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - copertina rigida, flessible
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
booklooker.de |
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - copertina rigida, flessible
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
booklooker.de |
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Altro …
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Costi di spedizione:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Altro …
Prugnaud, Jean-Louis:
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - copertina rigida, flessible2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - copertina rigida, flessible
2012
ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - copertina rigida, flessible
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Altro …
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Altro …
Dati bibliografici del miglior libro corrispondente
Autore: | |
Titolo: | |
ISBN: |
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities.
In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature.
This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the Eu
Informazioni dettagliate del libro - Biosimilars
EAN (ISBN-13): 9782817803357
ISBN (ISBN-10): 2817803353
Copertina rigida
Anno di pubblicazione: 20121130
Editore: Springer Editions
87 Pagine
Peso: 0,343 kg
Lingua: Englisch
Libro nella banca dati dal 2007-02-10T18:10:29+01:00 (Rome)
Pagina di dettaglio ultima modifica in 2022-08-19T11:29:49+02:00 (Rome)
ISBN/EAN: 9782817803357
ISBN - Stili di scrittura alternativi:
2-8178-0335-3, 978-2-8178-0335-7
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : jean hugues, john seymour, louis
Titolo del libro: leben auf dem lande
Dati dell'editore
Autore: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titolo: Biosimilars - A New Generation of Biologics
Editore: Springer; Springer Paris
90 Pagine
Anno di pubblicazione: 2012-11-21
Paris; FR
Stampato / Fatto in
Peso: 0,336 kg
Lingua: Inglese
128,39 € (DE)
131,99 € (AT)
142,00 CHF (CH)
POD
XVIII, 90 p.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BC; EA
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Altri libri che potrebbero essere simili a questo:
Ultimo libro simile:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< Per archiviare...